Hi Skiper, was overseas when you posted this. Had a decent amount in PRR at one stage and while not losing the shirt off my back I lost the sleeves--still believe the science is good but hard to see where this company can go from here-----IMHO much "safer" bets in low cap aussie biotechs with shareholder return potential are TIS and BDM